Generative AI chatbots for reliable cancer information: Evaluating web-search, multilingual, and reference capabilities of emerging large language models

Authors: Menz, Bradley D. ^a, Modi, Natansh D. ^a, Abuhelwa, Ahmad Y. ^b, Ruanglertboon, Warit ^{c, d}, Vitry, Agnes ^e, Gao, Yuan ^a, Li, Lee X. ^a, Chhetri, Rakchha ^a, Chu, Bianca ^a, Bacchi, Stephen ^f, Kichenadasse, Ganessan ^{a, g}, Shahnam, Adel ^h, Rowland, Andrew ^a, Sorich, Michael J. ^a, Hopkins, Ashley M. ^{a, ⁎, 1}

Source: In European Journal of Cancer 11 March 2025 218

Allogeneic hematopoietic stem cell transplant outcomes in adults with inherited myeloid malignancies

Authors: Saygin, Caner, Roloff, Gregory, Hahn, Christopher N., Chhetri, Rakchha, Gill, Saar, Elmariah, Hany, Talati, Chetasi, Nunley, Emma, Gao, Guimin, Kim, Aelin, Bishop, Michael, Kosuri, Satyajit, Das, Soma, Singhal, Deepak, Venugopal, Parvathy, Homan, Claire C., Brown, Anna, Scott, Hamish S., Hiwase, Devendra, Godley, Lucy A.

Source: In Blood Advances 28 February 2023 7(4):549-554

Outcomes following venetoclax‐based treatment in therapy‐related myeloid neoplasms

Authors: Shah, Mithun Vinod, Chhetri, Rakchha, Dholakia, Ruchita, Kok, Chung H., Gangat, Naseema, Alkhateeb, Hassan B., Al‐Kali, Aref, Patnaik, Mrinal M., Baranwal, Anmol, Greipp, Patricia T., He, Rong, Begna, Kebede H., Tiong, Ing Soo, Wei, Andrew H., Hiwase, Devendra

Source: American journal of hematology. 97(8):1013-1022

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100154857095.0x000001&indx=1&recIds=ETOCvdc_100154857095.0x000001

Respiratory Viruses Cause Late Morbidity in Recipients of Hematopoietic Stem Cell Transplantation

Authors: Marinelli, Tina, Wee, Li Yan A., Rowe, Emily, Chhetri, Rakchha, Friel, Oisin, Higgins, Geoffrey, Bardy, Peter, Singhal, Deepak, Pradhan, Alyssa, Crawford, Lucy, Hiwase, Devendra K.

Source: In Biology of Blood and Marrow Transplantation April 2020 26(4):782-788

Comprehensive geriatric assessment predicts azacitidine treatment duration and survival in older patients with myelodysplastic syndromes

Authors: Molga, Angela, Wall, Michelle, Chhetri, Rakchha, Wee, Li Yan, Singhal, Deepak, Edwards, Suzanne, Singhal, Nimit, Ross, David, To, Luen Bik, Caughey, Gillian, Shakib, Sepehr, Germing, Ulrich, To, Timothy, Hiwase, Devendra

Source: In Journal of Geriatric Oncology January 2020 11(1):114-120

Clinical Effectiveness of Conjugate Pneumococcal Vaccination in Hematopoietic Stem Cell Transplantation Recipients

Authors: Roberts, Matthew B., Bak, Narin, Wee, Li Yan A., Chhetri, Rakchha, Yeung, David T., Lewis, Ian, Hiwase, Devendra K.

Source: Biology of blood and marrow transplantation. 26(2):421-427

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100111596281.0x000001&indx=1&recIds=ETOCvdc_100111596281.0x000001

The burden of immune‐mediated refractoriness to platelet transfusions in myelodysplastic syndromes

Authors: Cheok, Kathleen P. L., Chhetri, Rakchha, Wee, Li Yan A., Friel, Oisin, Pham, Anh, Salvi, Arabelle, McRae, Simon, Bardy, Peter, Singhal, Deepak, Roxby, David J., Wood, Erica M., Hiwase, Devendra K.

Source: Transfusion. 60(10):2192-2198

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100109728864.0x000001&indx=1&recIds=ETOCvdc_100109728864.0x000001

Comparable Survival Following Allogeneic Haematopoietic Stem Cell Transplant Utilising HLA-Matched Vs Alternative Donors: A Single-Centre Retrospective, Consecutive Cohort Analysis

Authors: Cibich, Ms. Alia, Chhetri, Rakchha, Sharplin, Kirsty, Shanmuganathan, Naranie, Singhal, Deepak, Beligaswatte, Ashanka, Horvath, Noemi, Selby, Philip, Purins, Leanne, Stevens, Judith, Yeung, David T, Bardy, Peter, Hiwase, Devendra

Source: Transplantation and Cellular Therapy. 29(S):S236-S237

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100180673514.0x000001&indx=1&recIds=ETOCvdc_100180673514.0x000001

Incidence of Decreased Bone Mineral Density Post Allogeneic Haemopoietic Stem Cell Transplant: Single Institution Retrospective Analysis

Authors: Cibich, Ms. Alia, Schultz, Christopher, Sharplin, Kirsty, Chhetri, Rakchha, Selby, Philip, Shanmuganathan, Naranie, Singhal, Deepak, Yeung, David T, Bardy, Peter, Hiwase, Devendra

Source: Transplantation and Cellular Therapy. 29(S):S362-S363

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100180672608.0x000001&indx=1&recIds=ETOCvdc_100180672608.0x000001

The mutational burden of therapy-related myeloid neoplasms is similar to primary myelodysplastic syndrome but has a distinctive distribution

Authors: Singhal, Deepak, Wee, Li, Kutyna, Monika, Chhetri, Rakchha, Geoghegan, Joel, Schreiber, Andreas, Feng, Jinghua, Wang, Paul, Babic, Milena, Parker, Wendy, Hiwase, Smita, Edwards, Suzanne, Moore, Sarah, Branford, Susan, Kuzmanovic, Teodora, Singhal, Nimit, Gowda, Raghu, Brown, Anna, Arts, Peer, To, Luen, Bardy, Peter, Lewis, Ian, D'Andrea, Richard, Maciejewski, Jaroslaw, Scott, Hamish, Hahn, Christopher, Hiwase, Devendra

Source: Leukemia. 33(12):2842-2853

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100190908792.0x000001&indx=1&recIds=ETOCvdc_100190908792.0x000001

IDH-mutant myeloid neoplasms are associated with seronegative rheumatoid arthritis and innate immune activation

Authors: Hong, Lih En, Wechalekar, Mihir D., Kutyna, Monika, Small, Annabelle, Lim, Kelly, Thompson-Peach, Chloe, Li, Joule J., Chhetri, Rakchha, Scott, Hamish S., Brown, Anna, Hahn, Christopher N., Yeung, David T., Sajid, Salvia, Robinson, Nirmal, Thomas, Ranjeny, Branford, Susan, D’Andrea, Richard J., Samaraweera, Saumya E., Patnaik, Mrinal, Proudman, Susanna, Thomas, Daniel, Kok, Chung Hoow, Shah, Mithun V., Hiwase, Devendra K.

Source: In Blood 2 May 2024 143(18):1873-1877

Screening for deficits using the G8 and VES-13 in older patients with Myelodysplastic syndromes

Authors: Molga, Angela, Wall, Michelle, Wee, Li Yan A., Chhetri, Rakchha, Singhal, Deepak, Singhal, Nimit, To, Luen Bik, Shakib, Sepehr, To, Timothy, Hiwase, Devendra

Source: Journal of geriatric oncology. 11(1):128-130

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100095441103.0x000001&indx=1&recIds=ETOCvdc_100095441103.0x000001

Personalized risk model for predicting risk of acute coronary syndrome in patients with myelodysplastic syndromes

Authors: Montarello, Natalie, Leslie, Alasdair, Chhetri, Rakchha, Friel, Oisin, Singhal, Deepak, Ross, David, Yeung, David, Kok, Chung H., Psaltis, Peter J., Hiwase, Devendra K.

Source: In Blood Advances 11 July 2023 7(13):3032-3035

Factors Predicting Survival Following Allogeneic Stem Cell Transplant in Patients with Therapy-Related Myeloid Neoplasms

Authors: Baranwal, Anmol, Chhetri, Rakchha, Kok, Chung, Alkhateeb, Hassan B., Mangaonkar, Abhishek, Johnson, Bradley K., Clark, Matthew H., Cibich, Alia, Bardy, Peter, Hogan, William J., Litzow, Mark R., Hiwase, Devendra, Shah, Mithun V.

Source: Transplantation and Cellular Therapy. 28(S):S137-S138

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100157890964.0x000001&indx=1&recIds=ETOCvdc_100157890964.0x000001

TP53 mutation in therapy-related myeloid neoplasm defines a distinct molecular subtype

Authors: Hiwase, Devendra, Hahn, Christopher, Tran, Elizabeth Ngoc Hoa, Chhetri, Rakchha, Baranwal, Anmol, Al-Kali, Aref, Sharplin, Kirsty, Ladon, Dariusz, Hollins, Rachel, Greipp, Patricia, Kutyna, Monika, Alkhateeb, Hassan, Badar, Talha, Wang, Paul, Ross, David M., Singhal, Deepak, Shanmuganathan, Naranie, Bardy, Peter, Beligaswatte, Ashanka, Yeung, David, Litzow, Mark R., Mangaonkar, Abhishek, Giri, Pratyush, Lee, Cindy, Yong, Angie, Horvath, Noemi, Singhal, Nimit, Gowda, Raghu, Hogan, William, Gangat, Naseema, Patnaik, Mrinal, Begna, Kebede, Tiong, Ing S., Wei, Andrew, Kumar, Sharad, Brown, Anna, Scott, Hamish, Thomas, Daniel, Kok, Chung H., Tefferi, Ayalew, Shah, Mithun Vinod

Source: In Blood 2 March 2023 141(9):1087-1091

Characteristics and Outcomes of Radiation Therapy-Related Myeloid Neoplasms

Authors: Shultz, Carl T., Al-Kali, Aref, Baranwal, Anmol ^*, Chhetri, Rakchha ^*, Ngoc Hoa Tran, Elizabeth ^*, Arsana, Arini ^*, Alkhateeb, Hassan B. ^*, Stish, Bradley ^*, Tefferi, Ayalew, Patnaik, Mrinal M.M., Gangat, Naseema, Hiwase, Devendra, Shah, Mithun V.

Source: In Blood 15 November 2022 140 Supplement 1:6309-6311

Allogeneic Hematopoietic Stem Cell Transplant Outcomes in Adults with Inherited Myeloid Malignancies

Authors: Saygin, Caner, Roloff, Gregory W., Hahn, Christopher N, Chhetri, Rakchha ^*, Gill, Saar, Elmariah, Hany, Talati, Chetasi ^*, Nunley, Emma ^*, Gao, Guimin ^*, Kim, Aelin ^*, Bishop, Michael R., Kosuri, Satyajit ^*, Das, Soma ^*, Singhal, Deepak ^*, Venugopal, Parvathy, Homan, Claire ^*, Brown, Anna L., Scott, Hamish S, Hiwase, Devendra, Godley, Lucy A.

Source: In Blood 15 November 2022 140 Supplement 1:10542-10544

A Personalized Risk Model for Azacitidine Outcome in Myelodysplastic Syndrome and Other Myeloid Neoplasms Identified by Machine Learning Model Utilizing Real-World Data.

Authors: Sharplin, Kirsty, Proudman, William, Chhetri, Rakchha, Tran, Elizabeth Ngoc Hoa, Choong, Jamie, Kutyna, Monika, Selby, Philip, Sapio, Aidan, Friel, Oisin, Khanna, Shreyas, Singhal, Deepak, Damin, Michelle, Ross, David, Yeung, David, Thomas, Daniel, Kok, Chung H., Hiwase, Devendra

Source: Cancers; Aug2023, Vol. 15 Issue 16, p4019, 14p

Subject Terms: MYELODYSPLASTIC syndromes, MACHINE learning, MYELOID leukemia, RETROSPECTIVE studies, AZACITIDINE, TREATMENT effectiveness, COMPARATIVE studies, TREATMENT failure, RESEARCH funding, OVERALL survival

TP53 mutation variant allele frequency of ≥10% is associated with poor prognosis in therapy-related myeloid neoplasms.

Authors: Shah, Mithun Vinod, Tran, Elizabeth Ngoc Hoa, Shah, Syed, Chhetri, Rakchha, Baranwal, Anmol, Ladon, Dariusz, Shultz, Carl, Al-Kali, Aref, Brown, Anna L., Chen, Dong, Scott, Hamish S., Greipp, Patricia, Thomas, Daniel, Alkhateeb, Hassan B., Singhal, Deepak, Gangat, Naseema, Kumar, Sharad, Patnaik, Mrinal M., Hahn, Christopher N., Kok, Chung Hoow

Source: Blood Cancer Journal; 4/11/2023, Vol. 13 Issue 1, p1-9, 9p

Subject Terms: GENE frequency, TUMORS, GENETIC mutation, PROGNOSIS

Company/Entity: WORLD Health Organization

High Prevalence of IDH Mutation in Myeloid Neoplasm with Concomitant Autoimmune Rheumatic Disorders

Authors: Hong, Lih En, Kok, Chung Hoow, Kutyna, Monika, Li, Joule J, Chhetri, Rakchha, Ross, David M., Branford, Susan, Scott, Hamish S, Brown, Anna, Hahn, Christopher Norman, Yeung, David T, Patnaik, Mrinal M., Shah, Mithun V, Proudman, Susanna, Wechalekar, Mihir, Hiwase, Devendra

Source: In Blood 2 November 2023 142 Supplement 1:4621-4621